{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:27:32Z","timestamp":1792697252852,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["456155"],"award-info":[{"award-number":["456155"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["IN-15-003"],"award-info":[{"award-number":["IN-15-003"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009844","name":"PA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001168","name":"Cancer Council Queensland","doi-asserted-by":"publisher","award":["1041390"],"award-info":[{"award-number":["1041390"]}],"id":[{"id":"10.13039\/501100001168","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cell.2020.02.019","type":"journal-article","created":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T23:18:41Z","timestamp":1583709521000},"page":"895-914.e27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":192,"title":["Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies"],"prefix":"10.1016","volume":"180","author":[{"given":"Hui Yi","family":"Chew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila O.","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmina L.","family":"Gonzalez Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blerida","family":"Banushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godwins","family":"Echejoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon R.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake S.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Merida de Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Moi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mazzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeny","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Souza-Fonseca-Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Frazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dolcetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Cuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Panizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euan","family":"Walpole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2020.02.019_bib2","first-page":"379123","article-title":"Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity","volume":"2011","author":"Alderson","year":"2011","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.cell.2020.02.019_bib3","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1091\/mbc.e04-07-0591","article-title":"Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin","volume":"15","author":"Austin","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cell.2020.02.019_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13058-017-0900-z","article-title":"Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers","volume":"19","author":"Baldassarre","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib6","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1038\/s41598-017-05741-y","article-title":"Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis","volume":"7","author":"Bar-Yosef","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2020.02.019_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nm.2646","article-title":"The road to resistance: EGFR mutation and cetuximab","volume":"18","author":"Bardelli","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.02.019_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12967-015-0680-0","article-title":"Analysis of in\u00a0vitro ADCC and clinical response to trastuzumab: possible relevance of Fc\u03b3RIIIA\/Fc\u03b3RIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines","volume":"13","author":"Boero","year":"2015","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.cell.2020.02.019_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nature14067","article-title":"Endophilin marks\u00a0and controls a clathrin-independent endocytic pathway","volume":"517","author":"Boucrot","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.02.019_bib10","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/2326-6066.CIR-15-0059","article-title":"Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells","volume":"3","author":"Boyerinas","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2020.02.019_bib11","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/labinvest.2010.131","article-title":"Tumor-initiating activity and tumor morphology of HNSCC is modulated by interactions between clonal variants within the tumor","volume":"90","author":"Cameron","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.cell.2020.02.019_bib12","doi-asserted-by":"crossref","first-page":"e0006685","DOI":"10.1371\/journal.pntd.0006685","article-title":"Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies","volume":"12","author":"Carro","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2020.02.019_bib13","series-title":"BLA Multidisciplinary Review\u00a0and Evaluation: BLA 761049 Bavencio (Avelumab). reference no. 4073902","year":"2016"},{"key":"10.1016\/j.cell.2020.02.019_bib14","doi-asserted-by":"crossref","first-page":"25485","DOI":"10.1074\/jbc.M501707200","article-title":"Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase","volume":"280","author":"Chiang","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2020.02.019_bib15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.drudis.2016.04.005","article-title":"Targeting PRAS40 for multiple diseases","volume":"21","author":"Chong","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cell.2020.02.019_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2121-10-84","article-title":"Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src","volume":"10","author":"Chung","year":"2009","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.cell.2020.02.019_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":"Inhibitory Fc receptors modulate in\u00a0vivo cytotoxicity against tumor targets","volume":"6","author":"Clynes","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.02.019_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-08-3014","article-title":"TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2","volume":"69","author":"Copp","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1083\/jcb.127.4.915","article-title":"Induction of mutant dynamin specifically blocks endocytic coated vesicle formation","volume":"127","author":"Damke","year":"1994","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.cell.2020.02.019_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/tra.12272","article-title":"Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis","volume":"16","author":"Daniel","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.cell.2020.02.019_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2015.04.016","article-title":"Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect","volume":"161","author":"DiLillo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.02.019_bib22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1158\/2159-8290.CD-18-1259","article-title":"The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector","volume":"9","author":"Dong","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2020.02.019_bib23","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/lary.26679","article-title":"Barriers to generating PDX models of HPV-related head and neck cancer","volume":"127","author":"Facompre","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.cell.2020.02.019_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jneuroim.2016.12.014","article-title":"Inhibition of dopamine receptor D3 signaling in dendritic cells increases antigen cross-presentation to CD8+ T-cells favoring anti-tumor immunity","volume":"303","author":"Figueroa","year":"2017","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.cell.2020.02.019_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1083\/jcb.132.6.1011","article-title":"Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes","volume":"132","author":"Futter","year":"1996","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.cell.2020.02.019_bib26","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1091\/mbc.E14-09-1412","article-title":"Epidermal growth factor-stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis","volume":"26","author":"Garay","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cell.2020.02.019_bib27","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1158\/1078-0432.CCR-04-0225","article-title":"Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2","volume":"10","author":"Gennari","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib28","first-page":"1311","article-title":"Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model","volume":"1","author":"Goldstein","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/14712598.2017.1294156","article-title":"Avelumab: combining immune checkpoint inhibition and antibody-dependent cytotoxicity","volume":"17","author":"Hamilton","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.cell.2020.02.019_bib30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1349-7006.2008.00821.x","article-title":"Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity","volume":"99","author":"Hara","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cell.2020.02.019_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tcb.2012.10.007","article-title":"Targeting membrane trafficking in infection prophylaxis: dynamin inhibitors","volume":"23","author":"Harper","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cell.2020.02.019_bib32","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.18632\/oncotarget.24242","article-title":"Characterization of 7A7, an anti-mouse EGFR monoclonal antibody proposed to be the mouse equivalent of cetuximab","volume":"9","author":"He","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cell.2020.02.019_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4161\/cbt.10.2.12164","article-title":"Optical imaging predicts tumor response to anti-EGFR therapy","volume":"10","author":"Helman","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cell.2020.02.019_bib34","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/JVI.01557-09","article-title":"Dynamin- and clathrin-dependent endocytosis in African swine fever virus entry","volume":"84","author":"Hernaez","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.02.019_bib35","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1038\/s41598-017-07023-z","article-title":"Blockade of dengue virus infection and viral cytotoxicity in neuronal cells in\u00a0vitro and in\u00a0vivo by targeting endocytic pathways","volume":"7","author":"Ho","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2020.02.019_bib36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc1913","article-title":"Comparing antibody and small-molecule therapies for cancer","volume":"6","author":"Imai","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2020.02.019_bib37","doi-asserted-by":"crossref","first-page":"852748","DOI":"10.1155\/2014\/852748","article-title":"Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Mol. Biol. Int."},{"key":"10.1016\/j.cell.2020.02.019_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cell.2020.02.019_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jid.2018.06.190","article-title":"An Ex\u00a0Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes","volume":"139","author":"Joseph","year":"2019","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.cell.2020.02.019_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40425-017-0310-x","article-title":"Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after \u22651 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial","volume":"6","author":"Kaufman","year":"2018","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.cell.2020.02.019_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ijc.22370","article-title":"Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma","volume":"120","author":"Kawaguchi","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cell.2020.02.019_bib42","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/cncr.31293","article-title":"Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials","volume":"124","author":"Kelly","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.cell.2020.02.019_bib43","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1039\/C7SC01159H","article-title":"Single particle tracking-based reaction progress kinetic analysis reveals a series of molecular mechanisms of cetuximab-induced EGFR processes in a single living cell","volume":"8","author":"Kim","year":"2017","journal-title":"Chem. Sci. (Camb.)"},{"key":"10.1016\/j.cell.2020.02.019_bib44","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1349-7006.2007.00510.x","article-title":"Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor","volume":"98","author":"Kimura","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cell.2020.02.019_bib45","first-page":"3384","article-title":"Tumor-inhibitory antibodies to HER-2\/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2","volume":"60","author":"Klapper","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib46","first-page":"2595","article-title":"Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer","volume":"129","author":"Kohrt","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2020.02.019_bib47","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1158\/1078-0432.CCR-06-1726","article-title":"Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines","volume":"13","author":"Kurai","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1073\/pnas.012607799","article-title":"Dynamin at actin tails","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2020.02.019_bib49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/COH.0000000000000439","article-title":"Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?","volume":"13","author":"Lee","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.cell.2020.02.019_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/syn.21788","article-title":"Upregulated dynamin 1 in an acute seizure model and in epileptic patients","volume":"69","author":"Li","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.cell.2020.02.019_bib51","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.cub.2008.10.044","article-title":"The GTPase-activating protein GRAF1 regulates the CLIC\/GEEC endocytic pathway","volume":"18","author":"Lundmark","year":"2008","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cell.2020.02.019_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/acsinfecdis.5b00030","article-title":"Evaluation of Ebola Virus Inhibitors for Drug Repurposing","volume":"1","author":"Madrid","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.cell.2020.02.019_bib53","doi-asserted-by":"crossref","first-page":"e1075114","DOI":"10.1080\/2162402X.2015.1075114","article-title":"Repeated PD-1\/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer","volume":"5","author":"Mall","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.cell.2020.02.019_bib54","doi-asserted-by":"crossref","first-page":"12655","DOI":"10.1038\/s41598-017-12883-6","article-title":"Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity","volume":"7","author":"Mayr","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2020.02.019_bib55","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/tra.12119","article-title":"Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis","volume":"14","author":"McCluskey","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.cell.2020.02.019_bib56","doi-asserted-by":"crossref","first-page":"a016949","DOI":"10.1101\/cshperspect.a016949","article-title":"Endocytosis and cancer","volume":"5","author":"Mellman","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cell.2020.02.019_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cell.2020.02.019_bib58","first-page":"1933","article-title":"Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives","volume":"11","author":"Motohashi","year":"1991","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib59","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3389\/fimmu.2017.01544","article-title":"Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy","volume":"8","author":"Muntasell","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2020.02.019_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01518458","article-title":"Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma","volume":"37","author":"Naramura","year":"1993","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cell.2020.02.019_bib61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/13813450902988580","article-title":"PRAS40: target or modulator of\u00a0mTORC1 signalling and insulin action?","volume":"115","author":"Nascimento","year":"2009","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.cell.2020.02.019_bib62","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2337\/db05-1390","article-title":"Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats","volume":"55","author":"Nascimento","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cell.2020.02.019_bib63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ctrv.2016.11.007","article-title":"Resistance to PD1\/PDL1 checkpoint inhibition","volume":"52","author":"O\u2019Donnell","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cell.2020.02.019_bib64","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1158\/1078-0432.CCR-17-0186","article-title":"Systemic Antitumor Immunity by PD-1\/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors","volume":"24","author":"O\u2019Shaughnessy","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib65","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/cas.13330","article-title":"Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and\u00a0increases the efficacy of cancer immunotherapy","volume":"108","author":"Ohno","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cell.2020.02.019_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1309\/BTLN5WTMJ3PCNRRC","article-title":"Expression of protein tyrosine kinases in head and neck squamous cell carcinomas","volume":"124","author":"Ongkeko","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cell.2020.02.019_bib67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/1078-0432.CCR-11-2277","article-title":"Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma","volume":"18","author":"Pahl","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib68","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T\u00a0cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.02.019_bib69","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1479-5876-11-198","article-title":"Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers","volume":"11","author":"Peng","year":"2013","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.cell.2020.02.019_bib70","doi-asserted-by":"crossref","first-page":"e31993","DOI":"10.7554\/eLife.31993","article-title":"EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in\u00a0vivo","volume":"6","author":"Pinilla-Macua","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.cell.2020.02.019_bib71","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2020.02.019_bib72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc.2016.2","article-title":"Acquired resistance to immunotherapy and future challenges","volume":"16","author":"Restifo","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2020.02.019_bib73","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/2326-6066.CIR-15-0210","article-title":"PD-1 Blockade Expands Intratumoral Memory T Cells","volume":"4","author":"Ribas","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2020.02.019_bib74","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2015.03.005","article-title":"Antagonistic human Fc\u03b3RIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in\u00a0vivo","volume":"27","author":"Roghanian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2020.02.019_bib75","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/onc.2008.432","article-title":"Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity","volume":"28","author":"Scaltriti","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2020.02.019_bib76","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nm.3843","article-title":"Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models","volume":"21","author":"Schiffer","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.02.019_bib77","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2020.02.019_bib99","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2020.02.019_bib78","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2020.02.019_bib80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2013.00076","article-title":"Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies","volume":"4","author":"Seidel","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2020.02.019_bib81","doi-asserted-by":"crossref","first-page":"C904","DOI":"10.1152\/ajpcell.1986.251.6.C904","article-title":"Effects of phenothiazines on binding and processing of epidermal growth factor in 3T3 cells","volume":"251","author":"Selinfreund","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cell.2020.02.019_bib82","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T\u00a0cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.02.019_bib83","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3892\/or.2014.3077","article-title":"Cetuximab-mediated ADCC activity is correlated with the cell surface expression level of EGFR but not with the KRAS\/BRAF mutational status in colorectal cancer","volume":"31","author":"Seo","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cell.2020.02.019_bib84","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.02.019_bib85","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/jiu377","article-title":"Repurposing of prochlorperazine for use against dengue virus infection","volume":"211","author":"Simanjuntak","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2020.02.019_bib86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/10091","article-title":"SH3-domain-containing proteins function at distinct steps in clathrin-coated vesicle formation","volume":"1","author":"Simpson","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2020.02.019_bib87","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0889-8588(05)70243-4","article-title":"Antibody-directed, effector cell-mediated tumor destruction","volume":"15","author":"Sondel","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.cell.2020.02.019_bib88","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1158\/1078-0432.CCR-03-0549","article-title":"A comparison of the in\u00a0vitro and in\u00a0vivo activities of IgG and F(ab\u2019)2 fragments of a mixture of three monoclonal anti-Her-2 antibodies","volume":"10","author":"Spiridon","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib89","doi-asserted-by":"crossref","first-page":"e1217","DOI":"10.1371\/journal.pone.0001217","article-title":"PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis","volume":"2","author":"Thedieck","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2020.02.019_bib90","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1176\/ajp.124.7.978","article-title":"Phenothiazines and diabetes in hospitalized women","volume":"124","author":"Thonnard-Neumann","year":"1968","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cell.2020.02.019_bib91","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1158\/1078-0432.CCR-15-2971","article-title":"Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients","volume":"22","author":"Trivedi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2020.02.019_bib92","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/351411a0","article-title":"Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic","volume":"351","author":"van der Bliek","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.02.019_bib93","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/JVI.00347-16","article-title":"Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies","volume":"90","author":"von Bredow","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.02.019_bib100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2011.06.025","article-title":"Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition","volume":"146","author":"von Kleist","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.02.019_bib94","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","article-title":"NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy","volume":"6","author":"Wang","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2020.02.019_bib95","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cell.2020.02.019_bib96","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrclinonc.2010.97","article-title":"Understanding resistance to EGFR inhibitors-impact on future treatment strategies","volume":"7","author":"Wheeler","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2020.02.019_bib97","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4161\/cbt.8.9.8210","article-title":"PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells","volume":"8","author":"Zhang","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cell.2020.02.019_bib98","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.7150\/jca.20850","article-title":"Potential Roles of Peripheral Dopamine in Tumor Immunity","volume":"8","author":"Zhang","year":"2017","journal-title":"J.\u00a0Cancer"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009286742030163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009286742030163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:41:22Z","timestamp":1758800482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009286742030163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S009286742030163X"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2020.02.019","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2020.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}